The conundrum of differentiating Cushing's syndrome from non-neoplastic hypercortisolism: a systematic review and meta-analysis.

Neri Alejandro Alvarez-Villalobos, Alejandro Salcido-Montenegro, Carolina Quintanilla-Sánchez, José Gerardo González-González, José Miguel Hinojosa-Amaya, Maria Fleseriu, Fernando Díaz González-Colmenero, Pablo José Moreno-Peña, Dulce María Manzanares-Gallegos, Luis Fernando Gutiérrez-Dávila, Patricia Lizeth Castillo-Morales, Mariano García-Campa, Elena Varlamov, René Rodriguez-Gutiérrez

Journal: Pituitary 2024;27(4):345-359

PMID: 38888685

Full Text on Springer View on PubMed

Abstract

CONTEXT

Once hypercortisolemia is confirmed, differential diagnosis between Cushing's syndrome (CS) due to neoplastic endogenous hypercortisolism and non-neoplastic hypercortisolism (NNH, pseudo-Cushing's syndrome) is crucial. Due to worldwide corticotropin-releasing hormone (CRH) unavailability, accuracy of alternative tests to dexamethasone (Dex)-CRH, is clearly needed.

OBJECTIVE

Assess the diagnostic accuracy of Dex-CRH test, desmopressin stimulation test, midnight serum cortisol (MSC), and late-night salivary cortisol (LNSC) levels to distinguish CS from NNH.

METHODS

Articles through March 2022 were identified from Scopus, Web of Science, MEDLINE, EMBASE, and PubMed. All steps through the systematic review were performed independently and in duplicate and strictly adhered to the updated PRISMA-DTA checklist.

DATA SYNTHESIS

A total of 24 articles (1900 patients) were included. Dex-CRH had a pooled sensitivity and specificity of 91% (95%CI 87-94%; I 0%) and 82% (73-88%; I 50%), desmopressin test 86% (81-90%; I 28%) and 90% (84-94%; I 15%), MSC 91% (85-94%; I 66%) and 81% (70-89%; I 71%), and LNSC 80% (67-89%; I 57%) and 90% (84-93%; I 21%), respectively. Summary receiver operating characteristics areas under the curve were Dex-CRH 0.949, desmopressin test 0.936, MSC 0.942, and LNSC 0.950 without visual or statistical significance. The overall risk of studies bias was moderate.

CONCLUSION

Dex-CRH, the desmopressin stimulation test, and MSC have similar diagnostic accuracy, with Dex-CRH and MSC having slightly higher sensitivity, and the desmopressin test being more specific. LNSC was the least accurate, probably due to high heterogeneity, intrinsic variability, different assays, and lack of consistent reported cutoffs. When facing this challenging differential diagnosis, the results presented here should increase clinicians' confidence when deciding which test to perform.

Address: Pituitary Clinic, Endocrinology Division, Department of Medicine, Hospital Universitario "Dr. José E. González" Universidad Autónoma de Nuevo León, (Gonzalitos) S/N, Mitras Centro, 64460, Monterrey, Mexico.; Advanced Analysis Center of Scientific Information, Universidad Autónoma de Nuevo León School of Medicine, 64460, Monterrey, Mexico.; Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR, USA.; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA.; Pituitary Center, Oregon Health & Science University, Portland, OR, USA.; Pituitary Clinic, Endocrinology Division, Department of Medicine, Hospital Universitario "Dr. José E. González" Universidad Autónoma de Nuevo León, (Gonzalitos) S/N, Mitras Centro, 64460, Monterrey, Mexico. [email protected].; Advanced Analysis Center of Scientific Information, Universidad Autónoma de Nuevo León School of Medicine, 64460, Monterrey, Mexico. [email protected].; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. [email protected].; Department of Medicine, Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR, USA. [email protected].; Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA. [email protected].; Pituitary Center, Oregon Health & Science University, Portland, OR, USA. [email protected].

DOI: 10.1007/s11102-024-01408-w

Link outs

Free resources

Medical:

https://medlineplus.gov/cushingssyndrome.html

Subscription / membership required

Full Text Sources:

https://doi.org/10.1007/s11102-024-01408-w

MeSH Terms: Humans, Cushing Syndrome, Hydrocortisone, Diagnosis, Differential, Corticotropin-Releasing Hormone, Dexamethasone, Deamino Arginine Vasopressin